|
US6613942B1
(en)
|
1997-07-01 |
2003-09-02 |
Novo Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
CN1312807A
(zh)
|
1998-06-19 |
2001-09-12 |
希龙公司 |
糖元合成酶激酶3的抑制剂
|
|
US7045519B2
(en)
|
1998-06-19 |
2006-05-16 |
Chiron Corporation |
Inhibitors of glycogen synthase kinase 3
|
|
AR023052A1
(es)
|
1998-09-25 |
2002-09-04 |
Mitsuharu Yoshimura Milton |
Derivados de pirimidona
|
|
ATE258055T1
(de)
|
1998-11-04 |
2004-02-15 |
Smithkline Beecham Corp |
Pyridin-4-yl oder pyrimidin-4-yl substituierte pyrazine
|
|
US6350744B1
(en)
*
|
1998-11-20 |
2002-02-26 |
Merck & Co., Inc. |
Compounds having cytokine inhibitory activity
|
|
US6469018B1
(en)
|
1999-01-08 |
2002-10-22 |
Smithkline Beecham Corporation |
Compounds
|
|
US6503949B1
(en)
|
1999-05-17 |
2003-01-07 |
Noro Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
US7122666B2
(en)
|
1999-07-21 |
2006-10-17 |
Sankyo Company, Limited |
Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses
|
|
GB9927844D0
(en)
|
1999-11-26 |
2000-01-26 |
Glaxo Group Ltd |
Chemical compounds
|
|
US6906067B2
(en)
|
1999-12-28 |
2005-06-14 |
Bristol-Myers Squibb Company |
N-heterocyclic inhibitors of TNF-α expression
|
|
EP1246823A1
(en)
*
|
1999-12-28 |
2002-10-09 |
Pharmacopeia, Inc. |
Pyrimidine and triazine kinase inhibitors
|
|
GB0003224D0
(en)
*
|
2000-02-11 |
2000-04-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
EP1136489A1
(en)
*
|
2000-03-23 |
2001-09-26 |
Sanofi-Synthelabo |
2-[Piperidin-1-yl]pyrimidone derivatives
|
|
EP1136099A1
(en)
*
|
2000-03-23 |
2001-09-26 |
Sanofi-Synthelabo |
2-(Indolylalkylamino)pyrimidone derivatives as GSK3beta inhibitors
|
|
EP1136484A1
(en)
*
|
2000-03-23 |
2001-09-26 |
Sanofi-Synthelabo |
2-(Arylalkylamino)pyrimidone derivatives
|
|
EP1136483A1
(en)
*
|
2000-03-23 |
2001-09-26 |
Sanofi-Synthelabo |
2-[Piperazinyl]pyrimidone derivatives
|
|
EP1136482A1
(en)
*
|
2000-03-23 |
2001-09-26 |
Sanofi-Synthelabo |
2-Amino-3-(alkyl)-pyrimidone derivatives as GSK3beta inhibitors
|
|
EP1136485A1
(en)
*
|
2000-03-23 |
2001-09-26 |
Sanofi-Synthelabo |
Aminophenyl pyrimidone derivatives
|
|
WO2001070728A1
(en)
*
|
2000-03-23 |
2001-09-27 |
Sanofi-Synthelabo |
2-[nitrogen-heterocyclic]pyrimidone derivatives
|
|
EP1136491A1
(en)
*
|
2000-03-23 |
2001-09-26 |
Sanofi-Synthelabo |
2-[(Heteroaryl)alkylamino]pyrimidone derivatives
|
|
WO2001070727A1
(en)
*
|
2000-03-23 |
2001-09-27 |
Sanofi-Synthelabo |
2-(arylalkylamino)pyrimidone derivatives and 2-(heteroarylalkylamino)pyrimidone derivatives
|
|
EP1136486A1
(en)
*
|
2000-03-23 |
2001-09-26 |
Sanofi-Synthelabo |
2-[Indanylamino]pyrimidone and 2-[tetrahydronaphthalenylamino]pyrimidone derivatives
|
|
EP1136493A1
(en)
*
|
2000-03-23 |
2001-09-26 |
Sanofi-Synthelabo |
2-(Thienopyridinyl)pyrimidone, 2-(furopyridinyl)pyrimidone 2-(isoquinolinyl)pyrimidone, 2-(pyridoindolyl)pyrimidone and 2-(benzofuropyridinyl)pyrimidone derivatives
|
|
IL152023A0
(en)
|
2000-04-26 |
2003-04-10 |
Eisai Co Ltd |
Compounds having adenosine a2 receptor antagonism and pharmaceutical compositions containing the same
|
|
KR100840816B1
(ko)
*
|
2000-05-12 |
2008-06-23 |
젠자임 코포레이션 |
ＴＮＦ-α시그널링의 조절물질
|
|
US6562807B2
(en)
|
2000-06-23 |
2003-05-13 |
Novo Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
GB0021494D0
(en)
*
|
2000-09-01 |
2000-10-18 |
Glaxo Group Ltd |
Chemical comkpounds
|
|
WO2002020495A2
(en)
*
|
2000-09-06 |
2002-03-14 |
Chiron Corporation |
Inhibitors of glycogen synthase kinase 3
|
|
US6670362B2
(en)
|
2000-09-20 |
2003-12-30 |
Pfizer Inc. |
Pyridazine endothelin antagonists
|
|
US6821960B2
(en)
|
2000-11-17 |
2004-11-23 |
Noyo Nordisk Pharmaceuticals, Inc. |
Glucagon antagonists/inverse agonists
|
|
EP1345890A1
(en)
|
2000-11-17 |
2003-09-24 |
Novo Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
US6706744B2
(en)
|
2000-11-17 |
2004-03-16 |
Novo Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
GB0112802D0
(en)
|
2001-05-25 |
2001-07-18 |
Glaxo Group Ltd |
Pyrimidine derivatives
|
|
GB0112810D0
(en)
|
2001-05-25 |
2001-07-18 |
Glaxo Group Ltd |
Pyrimidine derivatives
|
|
GB0119477D0
(en)
*
|
2001-08-09 |
2001-10-03 |
Glaxo Group Ltd |
Pyrimidine derivatives
|
|
CN1810802B
(zh)
*
|
2001-09-21 |
2011-04-27 |
三菱制药株式会社 |
3-取代的-4-嘧啶酮衍生物
|
|
AU2002337499B2
(en)
|
2001-09-21 |
2007-08-23 |
Mitsubishi Pharma Corporation |
3-substituted-4-pyrimidone derivatives
|
|
IL160701A0
(en)
|
2001-09-21 |
2004-08-31 |
Mitsubishi Pharma Corp |
3-substituted-4-pyrimidone derivatives
|
|
TWI301834B
(en)
*
|
2001-10-22 |
2008-10-11 |
Eisai R&D Man Co Ltd |
Pyrimidone compound and pharmaceutical composition including the same
|
|
TWI330183B
(enExample)
*
|
2001-10-22 |
2010-09-11 |
Eisai R&D Man Co Ltd |
|
|
US6921762B2
(en)
|
2001-11-16 |
2005-07-26 |
Amgen Inc. |
Substituted indolizine-like compounds and methods of use
|
|
US6762318B2
(en)
|
2001-12-03 |
2004-07-13 |
Novo Nordisk A/S |
Glucagon antagonists
|
|
US6881746B2
(en)
|
2001-12-03 |
2005-04-19 |
Novo Nordick A/S |
Glucagon antagonists/inverse agonists
|
|
AR038368A1
(es)
|
2002-02-01 |
2005-01-12 |
Novartis Ag |
Compuestos n-pirimidin-2-il-aminas sustituidas como inhibidores de ige, una composicion farmaceutica y el uso de dichos compuestos para la preparacion de un medicamento
|
|
EP1476428B1
(en)
|
2002-02-22 |
2010-11-17 |
Pharmacia & Upjohn Company LLC |
Pyridyl sulfone derivatives as 5-ht6 receptor ligands
|
|
MXPA04008364A
(es)
*
|
2002-02-28 |
2005-07-26 |
Sanofi Aventis |
Derivados de 2-piridinil y 2-pirimidinil-6, 7, 8, 9-tetrahidropirmido [1,2-a] pirimidin-4-ona substituidos por heteroarilo.
|
|
AU2003216591A1
(en)
*
|
2002-04-10 |
2003-10-20 |
Orichid Chemicals And Pharmaceuticals Limited |
Amino substituted pyrimidinone derivatives useful in the treatment of inflammation and immunological
|
|
MXPA04011470A
(es)
*
|
2002-05-21 |
2005-02-14 |
Amgen Inc |
Compuestos heterociclicos sustituidos y metodos de uso.
|
|
ES2278170T3
(es)
|
2002-07-09 |
2007-08-01 |
BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG |
Composiciones farmaceuticas de anticolinergicos e inhibidores de la quinasa p38 en el tratamiento de enfermedades respiratorias.
|
|
DE60305053T2
(de)
|
2002-08-19 |
2006-08-31 |
Glaxo Group Ltd., Greenford |
Pyrimidinderivate als selektive cox-2-inhibitoren
|
|
GB0221443D0
(en)
|
2002-09-16 |
2002-10-23 |
Glaxo Group Ltd |
Pyridine derivates
|
|
NZ541074A
(en)
|
2002-12-16 |
2008-04-30 |
Mitsubishi Pharma Corp |
3-Substituted-4-pyrimidone derivatives
|
|
WO2004069846A1
(de)
*
|
2003-02-06 |
2004-08-19 |
Basf Aktiengesellschaft |
Pyrimidine, verfahren zu deren herstellung sowie deren verwendung
|
|
TWI357408B
(en)
|
2003-03-26 |
2012-02-01 |
Mitsubishi Tanabe Pharma Corp |
3-substituted-4-pyrimidone derivatives
|
|
AU2004257289A1
(en)
|
2003-07-16 |
2005-01-27 |
Neurogen Corporation |
Biaryl piperazinyl-pyridine analogues
|
|
US20050054663A1
(en)
*
|
2003-08-13 |
2005-03-10 |
Bennett Christina N. |
GSK-3 inhibitors
|
|
CA2535644A1
(en)
|
2003-08-20 |
2005-03-03 |
Amgen Inc. |
Substituted pyrimdinone derivatives and methods of use
|
|
GB0323137D0
(en)
|
2003-10-03 |
2003-11-05 |
Chang Lisa C W |
2,4,6- Trisubstituted pyrimidines and their different uses
|
|
US7897607B2
(en)
|
2004-04-07 |
2011-03-01 |
Takeda Pharmaceutical Company Limited |
Cyclic compounds
|
|
US20060035893A1
(en)
|
2004-08-07 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
|
|
MY145822A
(en)
|
2004-08-13 |
2012-04-30 |
Neurogen Corp |
Substituted biaryl piperazinyl-pyridine analogues
|
|
PE20060777A1
(es)
|
2004-12-24 |
2006-10-06 |
Boehringer Ingelheim Int |
Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
|
|
EA015890B1
(ru)
*
|
2005-06-14 |
2011-12-30 |
Тайджен Байотекнолоджи Ко. Лтд. |
Производные пиримидина
|
|
US8193206B2
(en)
|
2005-06-14 |
2012-06-05 |
Taigen Biotechnology Co., Ltd. |
Pyrimidine compounds
|
|
ES2270715B1
(es)
|
2005-07-29 |
2008-04-01 |
Laboratorios Almirall S.A. |
Nuevos derivados de pirazina.
|
|
US9296697B2
(en)
|
2005-08-24 |
2016-03-29 |
Abbott Laboratories |
Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-HT5-receptors
|
|
ES2274712B1
(es)
|
2005-10-06 |
2008-03-01 |
Laboratorios Almirall S.A. |
Nuevos derivados imidazopiridina.
|
|
EP2079728B1
(en)
|
2006-10-10 |
2013-09-25 |
Amgen Inc. |
N-aryl pyrazole compounds for use against diabetes
|
|
EP1992344A1
(en)
|
2007-05-18 |
2008-11-19 |
Institut Curie |
P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
|
|
WO2009013348A2
(en)
*
|
2007-07-26 |
2009-01-29 |
Novartis Ag |
Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions
|
|
DK2268635T3
(en)
|
2008-04-21 |
2015-09-14 |
Taigen Biotechnology Co Ltd |
Heterocyclic Compounds
|
|
TW201021855A
(en)
|
2008-11-13 |
2010-06-16 |
Taigen Biotechnology Co Ltd |
Lyophilization formulation
|
|
ES2646835T3
(es)
|
2010-10-18 |
2017-12-18 |
Cerenis Therapeutics Holding Sa |
Compuestos, composiciones y procedimientos útiles para la movilización del colesterol
|
|
GB201106829D0
(en)
|
2011-04-21 |
2011-06-01 |
Proximagen Ltd |
Heterocyclic compounds
|
|
WO2012085745A1
(en)
|
2010-12-23 |
2012-06-28 |
Pfizer Inc. |
Glucagon receptor modulators
|
|
PT2673260T
(pt)
|
2011-02-08 |
2016-10-24 |
Pfizer |
Modulador do recetor de glucagon
|
|
JP5647379B2
(ja)
|
2011-07-22 |
2014-12-24 |
ファイザー・インク |
キノリニルグルカゴン受容体モジュレーター
|
|
SG11201401531RA
(en)
|
2011-11-11 |
2014-07-30 |
Pfizer |
2-thiopyrimidinones
|
|
CA2929394C
(en)
|
2013-12-19 |
2021-11-16 |
Sunshine Lake Pharma Co., Ltd. |
Nitrogenous heterocyclic derivatives and their application in drugs
|
|
TWI651310B
(zh)
*
|
2014-02-20 |
2019-02-21 |
日商日本煙草產業股份有限公司 |
三化合物及其醫藥用途
|
|
BR112017022340A2
(pt)
|
2015-05-05 |
2018-07-10 |
Pfizer |
2-tiopirimidinonas
|
|
AR105711A1
(es)
|
2015-08-17 |
2017-11-01 |
Japan Tobacco Inc |
Compuestos de hidroxitriazina y sus usos farmacéuticos
|
|
DK3372589T3
(da)
|
2015-10-29 |
2021-12-06 |
Aska Pharm Co Ltd |
Pyrimidinderivat
|
|
LT3371165T
(lt)
*
|
2015-11-04 |
2022-05-10 |
Merck Patent Gmbh |
Btk inhibitorius, naudojamas vėžiui gydyti
|
|
NZ741294A
(en)
*
|
2015-11-17 |
2023-07-28 |
Merck Patent Gmbh |
Methods for treating multiple sclerosis using pyrimidine and pyridine compounds with btk inhibitory activity
|
|
TW201811766A
(zh)
|
2016-08-29 |
2018-04-01 |
瑞士商諾華公司 |
N-(吡啶-2-基)吡啶-磺醯胺衍生物及其用於疾病治療之用途
|
|
CA3157798A1
(en)
*
|
2019-11-12 |
2021-05-20 |
Zhongli Gao |
6-membered heteroarylaminosulfonamides for treating diseases and conditions mediated by deficient cftr activity
|
|
CN120379982A
(zh)
|
2022-12-02 |
2025-07-25 |
纽摩拉治疗公司 |
治疗神经障碍的方法
|